N

Nexstim Oyj
OMXH:NXTMH

Watchlist Manager
Nexstim Oyj
OMXH:NXTMH
Watchlist
Price: 5.48 EUR
Market Cap: 37.1m EUR
Have any thoughts about
Nexstim Oyj?
Write Note

Intrinsic Value

The intrinsic value of one NXTMH stock under the Base Case scenario is 4.38 EUR. Compared to the current market price of 5.48 EUR, Nexstim Oyj is Overvalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NXTMH Intrinsic Value
4.38 EUR
Overvaluation 20%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation Backtest
Nexstim Oyj

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NXTMH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NXTMH?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Nexstim Oyj

Provide an overview of the primary business activities
of Nexstim Oyj.

What unique competitive advantages
does Nexstim Oyj hold over its rivals?

What risks and challenges
does Nexstim Oyj face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nexstim Oyj.

Provide P/S
for Nexstim Oyj.

Provide P/E
for Nexstim Oyj.

Provide P/OCF
for Nexstim Oyj.

Provide P/FCFE
for Nexstim Oyj.

Provide P/B
for Nexstim Oyj.

Provide EV/S
for Nexstim Oyj.

Provide EV/GP
for Nexstim Oyj.

Provide EV/EBITDA
for Nexstim Oyj.

Provide EV/EBIT
for Nexstim Oyj.

Provide EV/OCF
for Nexstim Oyj.

Provide EV/FCFF
for Nexstim Oyj.

Provide EV/IC
for Nexstim Oyj.

Show me price targets
for Nexstim Oyj made by professional analysts.

What are the Revenue projections
for Nexstim Oyj?

How accurate were the past Revenue estimates
for Nexstim Oyj?

What are the Net Income projections
for Nexstim Oyj?

How accurate were the past Net Income estimates
for Nexstim Oyj?

What are the EPS projections
for Nexstim Oyj?

How accurate were the past EPS estimates
for Nexstim Oyj?

What are the EBIT projections
for Nexstim Oyj?

How accurate were the past EBIT estimates
for Nexstim Oyj?

Compare the revenue forecasts
for Nexstim Oyj with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nexstim Oyj and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nexstim Oyj against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nexstim Oyj compared to its peers.

Compare the P/E ratios
of Nexstim Oyj against its peers.

Discuss the investment returns and shareholder value creation
comparing Nexstim Oyj with its peers.

Analyze the financial leverage
of Nexstim Oyj compared to its main competitors.

Show all profitability ratios
for Nexstim Oyj.

Provide ROE
for Nexstim Oyj.

Provide ROA
for Nexstim Oyj.

Provide ROIC
for Nexstim Oyj.

Provide ROCE
for Nexstim Oyj.

Provide Gross Margin
for Nexstim Oyj.

Provide Operating Margin
for Nexstim Oyj.

Provide Net Margin
for Nexstim Oyj.

Provide FCF Margin
for Nexstim Oyj.

Show all solvency ratios
for Nexstim Oyj.

Provide D/E Ratio
for Nexstim Oyj.

Provide D/A Ratio
for Nexstim Oyj.

Provide Interest Coverage Ratio
for Nexstim Oyj.

Provide Altman Z-Score Ratio
for Nexstim Oyj.

Provide Quick Ratio
for Nexstim Oyj.

Provide Current Ratio
for Nexstim Oyj.

Provide Cash Ratio
for Nexstim Oyj.

What is the historical Revenue growth
over the last 5 years for Nexstim Oyj?

What is the historical Net Income growth
over the last 5 years for Nexstim Oyj?

What is the current Free Cash Flow
of Nexstim Oyj?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nexstim Oyj.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nexstim Oyj

Current Assets 6.7m
Cash & Short-Term Investments 3m
Receivables 2.1m
Other Current Assets 1.5m
Non-Current Assets 4.5m
Long-Term Investments 695.5k
PP&E 403.8k
Intangibles 3.4m
Current Liabilities 4.5m
Accounts Payable 591.6k
Accrued Liabilities 918.3k
Other Current Liabilities 3m
Non-Current Liabilities 4.9m
Long-Term Debt 4.9m
Efficiency

Earnings Waterfall
Nexstim Oyj

Revenue
7.9m EUR
Cost of Revenue
-218.7k EUR
Gross Profit
7.7m EUR
Operating Expenses
-8.4m EUR
Operating Income
-704.9k EUR
Other Expenses
-128.2k EUR
Net Income
-833.1k EUR

Free Cash Flow Analysis
Nexstim Oyj

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NXTMH Profitability Score
Profitability Due Diligence

Nexstim Oyj's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
ROIC is Increasing
Exceptional Revenue Growth Forecast
33/100
Profitability
Score

Nexstim Oyj's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

NXTMH Solvency Score
Solvency Due Diligence

Nexstim Oyj's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average Altman Z-Score
34/100
Solvency
Score

Nexstim Oyj's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NXTMH Price Targets Summary
Nexstim Oyj

Wall Street analysts forecast NXTMH stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NXTMH is 4.08 EUR with a low forecast of 4.04 EUR and a high forecast of 4.2 EUR.

Lowest
Price Target
4.04 EUR
26% Downside
Average
Price Target
4.08 EUR
26% Downside
Highest
Price Target
4.2 EUR
23% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NXTMH?

Click here to dive deeper.

Dividends

Nexstim Oyj
does not pay dividends
Shareholder Yield

Current shareholder yield for NXTMH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Nexstim Oyj

Country

Finland

Industry

Health Care

Market Cap

37.1m EUR

Dividend Yield

0%

Description

Nexstim Oyj engages in the provision of medical technology products. The company is headquartered in Helsinki, Etela-Suomen and currently employs 37 full-time employees. The company went IPO on 2014-11-14. The company is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.

Contact

ETELA-SUOMEN
Helsinki
Elimaenkatu 9 B
+35892727170
www.nexstim.com

IPO

2014-11-14

Employees

37

Officers

Chief Executive Officer
Mr. Mikko Karvinen
Chief Financial Officer
Mr. Joonas Juokslahti
Vice President of Sales & Marketing
Mr. Henri Hannula

See Also

Discover More
What is the Intrinsic Value of one NXTMH stock?

The intrinsic value of one NXTMH stock under the Base Case scenario is 4.38 EUR.

Is NXTMH stock undervalued or overvalued?

Compared to the current market price of 5.48 EUR, Nexstim Oyj is Overvalued by 20%.

Back to Top